Part of its extensive MEMS-oriented technology offering, the company is now able to provide a large variety of process capabilities for silicon- based microfluidic systems. Combined with a highly standardised foundry approach, this will help to remove barriers to market entry and shorten development cycles. The moves comes in response to increased demand for these systems.
Over the past five years the company X-FAB has invested over $25million in this area and, in the process, has established itself as a leading foundry with regard to the integration of silicon-based microfluidics.
The company has undertaken numerous projects for medical and industrial clients including: applications such as lab-on-a-chip, DNA sequencing and synthesis, cancer diagnostics, etc.
- Noble metal electrode arrays
- Inorganic layers for surface passivation and protection
- Deep silicon trenches and cavities
- Bonded silicon or glass lid wafers
- Polymeric fluidic structures
“We are seeing a growing number of requests to implement silicon-based microfluidics. As a consequence, our engineering team is striving to bring two worlds together; so that medical OEMs' deep understanding of physiology and fluid analysis can be combined with X-FAB’s knowledge of high-volume semiconductor manufacturing technologies,” said Volker Herbig, VP of X-FAB’s MEMS business unit. “We are excited to help our medical customers in developing their smart integrated microfluidic systems via the multitude of new process capabilities we can now offer.”